This is a multi-centre population-based follow-up study for all 504 patients with laboratory-confirmed COVID-19. This study establishes a standardized and structured clinical database to provide complete and multidimensional clinical diagnosis and treatment data of novel coronavirus pneumonia, which also support future epidemiological, infectious disease study and patients' prognosis, by collecting clinical data and the related data of patients with novel coronavirus pneumonia in Southern Zhejiang province.
The follow-up information will be collected in one-month, three-month, six-month and one-year after discharge. Information about symptoms, radiographic and laboratory findings, lung function, SF-36 QUESTIONNAIRE, antibody of COVID19，result of RT-PCR Test and suvival information will be collected through all time frames.
Study Type
OBSERVATIONAL
Enrollment
504
Wenzhou Medical University
Wenzhou, Zhejiang, China
The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
36-Item Short Form Survey Instrument (SF-36)
sum score of SF 36 form in each time frame
Time frame: one month, three month, six month and one year after discharge, minimum score
the value of FEV1 by lung function test
Time frame: one month, three month, six month and one year after discharge
the ratio of FEV1 to FVC by lung function test
Time frame: one month, three month, six month and one year after discharge
the predicted value of FEV1 by lung function test
Time frame: one month, three month, six month and one year after discharge
the predicted ratio of FEV1 to FVC by lung function test
Time frame: one month, three month, six month and one year after discharge
Lymphocyte value
laboratory result
Time frame: one month, three month, six month and one year after discharge
Neutrophil value
laboratory result
Time frame: one month, three month, six month and one year after discharge
DDI value
laboratory result
Time frame: one month, three month, six month and one year after discharge
the proportion of applying ACEIs/ARBs medication
collect the number of applying ACEIs/ARBs medication and calculate the proportion
Time frame: from the date of hospital admission to the day of hospital discharge
number of clinical symptoms after hospital discharge
clinical symptoms
Time frame: one month, three month, six month and one year after discharge
number of cases returning to positive result in RT-PCR test
Time frame: one month, three month, six month and one year after discharge
Number of positive outcome of IgG for antibody of COVID-19
Time frame: one month, three month, six month and one year after discharge
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.